SPINA-GBeta
SPINA-GBeta is a calculated biomarker for pancreatic beta cell function.
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
SPINA-GBeta is a calculated biomarker for pancreatic beta cell function. It represents the maximum amount of insulin that beta cells can produce per time-unit (e.g. in one second). The method of calculation is based on a time-discrete nonlinear feedback model of insulin-glucose homeostasis that is rooted in the MiMe-NoCoDI modeling platform for endocrine systems.
How to determine G Beta
The index is derived from a mathematical model of insulin-glucose homeostasis that incorporates fundamental physiological motifs. For diagnostic purposes, it is calculated from fasting insulin and glucose concentrations with: {\widehat{G}}_{\beta }=\frac{[I](\infty )({D}_{\beta }+\left[G\right](\infty ))}{{G}_{3}[G](\infty )} .
[I](∞): Fasting Insulin plasma concentration (mol/L) [G](∞): Fasting blood glucose concentration (mol/L) D β : EC 50 for glucose at beta cells (7 mmol/L) G 3 : Parameter for pharmacokinetics (58,8 s/L)
Reliability
In repeated measurements, SPINA-GBeta had higher retest reliability than HOMA-Beta, a measurement for beta cell function from the homeostasis model assessment.
Clinical utility
In the FAST study, an observational case-control sequencing study including 300 persons from Germany, SPINA-GBeta differed more clearly between subjects with and without diabetes than the corresponding HOMA-Beta index.
Pathophysiological implications
In several populations, SPINA-GBeta correlated with the area under the glucose curve and 2-hour concentrations of glucose, insulin and proinsulin in oral glucose tolerance testing, concentrations of free fatty acids, ghrelin and adiponectin, and the HbA1c fraction. SPINA-GBeta declines with increasing adherence to mediterranean diet, which has been explained with a reduction in the chronic stimulus for dynamical compensation, i.e. insulin hypersecretion .
In hidradenitis suppurativa, an inflammatory skin disease, SPINA-GBeta is increased to compensate for reduced insulin sensitivity. This dynamical compensation is insufficient, however, in a subset of affected patients, resulting in a reduced static disposition index (SPINA-DI) and the onset of diabetes mellitus.
Since SPINA-GBeta has higher predictive power than HOMA-Beta, its use has been suggested as a calculated early biomarker for the evolution and pathophysiology of gestational diabetes.
Predictive aspects
In a longitudinal evaluation of the NHANES study, a large sample of the general US population, over 10 years, reduced SPINA-GBeta significantly predicted all-cause mortality.
External links
Open source software for calculating SPINA-GBeta and other parameters for endotyping glucose homeostasis. (Permanent DOI), (General information and US mirror) Functions for R and S for calculating SPINA-GBeta, SPINA-GR and SPINA-DI. (Permanent DOI) Package "SPINA" for the statistical environment R
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377483506 under CC BY-SA 4.0; modifications have been made.